{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:59Z","timestamp":1771054499711,"version":"3.50.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LE952\/3-2"],"award-info":[{"award-number":["LE952\/3-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union Horizon 2020 Framework"},{"name":"APERIM","award":["633592"],"award-info":[{"award-number":["633592"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Motivation<\/jats:title><jats:p>Breast cancer is the second leading cause of cancer death among women. Tumors, even of the same histopathological subtype, exhibit a high genotypic diversity that impedes therapy stratification and that hence must be accounted for in the treatment decision-making process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Here, we present ClinOmicsTrailbc, a comprehensive visual analytics tool for breast cancer decision support that provides a holistic assessment of standard-of-care targeted drugs, candidates for drug repositioning and immunotherapeutic approaches. To this end, our tool analyzes and visualizes clinical markers and (epi-)genomics and transcriptomics datasets to identify and evaluate the tumor\u2019s main driver mutations, the tumor mutational burden, activity patterns of core cancer-relevant pathways, drug-specific biomarkers, the status of molecular drug targets and pharmacogenomic influences. In order to demonstrate ClinOmicsTrailbc\u2019s rich functionality, we present three case studies highlighting various ways in which ClinOmicsTrailbc can support breast cancer precision medicine. ClinOmicsTrailbc is a powerful integrated visual analytics tool for breast cancer research in general and for therapy stratification in particular, assisting oncologists to find the best possible treatment options for their breast cancer patients based on actionable, evidence-based results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Availability and implementation<\/jats:title><jats:p>ClinOmicsTrailbc can be freely accessed at https:\/\/clinomicstrail.bioinf.uni-sb.de.<\/jats:p><\/jats:sec><jats:sec><jats:title>Supplementary information<\/jats:title><jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p><\/jats:sec>","DOI":"10.1093\/bioinformatics\/btz302","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T11:09:40Z","timestamp":1555672180000},"page":"5171-5181","source":"Crossref","is-referenced-by-count":16,"title":["ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-4501","authenticated-orcid":false,"given":"Lara","family":"Schneider","sequence":"first","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Saarbr\u00fccken Graduate School of Computer Science , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-7566","authenticated-orcid":false,"given":"Tim","family":"Kehl","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Saarbr\u00fccken Graduate School of Computer Science , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Thedinga","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja Liddy","family":"Grammes","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9330-9290","authenticated-orcid":false,"given":"Christina","family":"Backes","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Chair for Clinical Bioinformatics, Saarland Informatics Campus, Saarland University , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mohr","sequence":"additional","affiliation":[{"name":"Quantitative Biology Center (QBiC) , T\u00fcbingen, Germany"},{"name":"Institute for Translational Bioinformatics, University Hospital T\u00fcbingen , T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schubert","sequence":"additional","affiliation":[{"name":"Department of Systems Biology , Boston, MA, USA"},{"name":"Department of Cell Biology, Harvard Medical School , Boston, MA, USA"},{"name":"cBio Center, Dana-Farber Cancer Institute , Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Lenhof","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Saarbr\u00fccken Graduate School of Computer Science , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-8796","authenticated-orcid":false,"given":"Nico","family":"Gerstner","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Saarbr\u00fccken Graduate School of Computer Science , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Daniel","family":"Hartkopf","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of T\u00fcbingen , T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Wallwiener","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Heidelberg , Heidelberg, Germany"},{"name":"National Center for Tumor Diseases, University of Heidelberg , Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1739-4598","authenticated-orcid":false,"given":"Oliver","family":"Kohlbacher","sequence":"additional","affiliation":[{"name":"Quantitative Biology Center (QBiC) , T\u00fcbingen, Germany"},{"name":"Institute for Translational Bioinformatics, University Hospital T\u00fcbingen , T\u00fcbingen, Germany"},{"name":"Center for Bioinformatics, University of T\u00fcbingen , T\u00fcbingen, Germany"},{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen , T\u00fcbingen, Germany"},{"name":"Biomolecular Interactions, Max Planck Institute for Developmental Biology , T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Keller","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Chair for Clinical Bioinformatics, Saarland Informatics Campus, Saarland University , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckart","family":"Meese","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Human Genetics, Saarland University , Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2248-323X","authenticated-orcid":false,"given":"Norbert","family":"Graf","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"},{"name":"Department of Pediatric Oncology and Hematology, Medical School, Saarland University , Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Lenhof","sequence":"additional","affiliation":[{"name":"Center for Bioinformatics , Saarbr\u00fccken, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"2023013108380203800_btz302-B1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2006.07.001","article-title":"Structure\u2013function relationship of estrogen receptor \u03b1 and \u03b2: impact on human health","volume":"27","author":"Ascenzi","year":"2006","journal-title":"Mol. Aspects Med"},{"key":"2023013108380203800_btz302-B2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc"},{"key":"2023013108380203800_btz302-B3","first-page":"269","article-title":"Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk","volume":"60","author":"Bo\u017eina","year":"2009","journal-title":"Arch. Ind. Hygiene Toxicol"},{"key":"2023013108380203800_btz302-B4","first-page":"1","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precision Oncol"},{"key":"2023013108380203800_btz302-B6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"Costello","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"2023013108380203800_btz302-B7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"2023013108380203800_btz302-B8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1742-1241.2007.01587.x","article-title":"The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer","volume":"61","author":"Fabian","year":"2007","journal-title":"Int. J. Clin. Pract"},{"key":"2023013108380203800_btz302-B9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1412379","article-title":"Adjuvant ovarian suppression in premenopausal breast cancer","volume":"372","author":"Francis","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"2023013108380203800_btz302-B10","first-page":"2013","article-title":"Preclinical evidence that PD-1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors","volume":"2685","author":"Fu","year":"2014","journal-title":"Cancer Res"},{"key":"2023013108380203800_btz302-B11","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.febslet.2014.02.005","article-title":"Deregulation of cell signaling in cancer","volume":"588","author":"Giancotti","year":"2014","journal-title":"FEBS Lett"},{"key":"2023013108380203800_btz302-B12","first-page":"1233","article-title":"Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factor","volume":"23","author":"Goetz","year":"2009","journal-title":"Oncol. Williston Park"},{"key":"2023013108380203800_btz302-B13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/1471-2407-14-769","article-title":"High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype","volume":"14","author":"Golubovskaya","year":"2014","journal-title":"BMC Cancer"},{"key":"2023013108380203800_btz302-B14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nmeth.2642","article-title":"IntOGen-mutations identifies cancer drivers across tumor types","volume":"10","author":"Gonzalez-Perez","year":"2013","journal-title":"Nat. Methods"},{"key":"2023013108380203800_btz302-B15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncb1235","article-title":"Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin","volume":"7","author":"Gonzalo","year":"2005","journal-title":"Nat. Cell Biol"},{"key":"2023013108380203800_btz302-B16","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther"},{"key":"2023013108380203800_btz302-B17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat. Genet"},{"key":"2023013108380203800_btz302-B18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"2023013108380203800_btz302-B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/446145a","article-title":"Drivers and passengers","volume":"446","author":"Haber","year":"2007","journal-title":"Nature"},{"key":"2023013108380203800_btz302-B20","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for The ENCODE Project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res"},{"key":"2023013108380203800_btz302-B21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2023013108380203800_btz302-B22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat. Commun"},{"key":"2023013108380203800_btz302-B23","doi-asserted-by":"crossref","first-page":"e1601737.","DOI":"10.1126\/sciadv.1601737","article-title":"The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer","volume":"2","author":"Law","year":"2016","journal-title":"Sci. Adv"},{"key":"2023013108380203800_btz302-B24","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023013108380203800_btz302-B25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"2023013108380203800_btz302-B26","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023013108380203800_btz302-B27","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"Maaten","year":"2008","journal-title":"J. Mach. Learn. Res"},{"key":"2023013108380203800_btz302-B28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science (New York, N.Y.)"},{"key":"2023013108380203800_btz302-B29","doi-asserted-by":"crossref","first-page":"122.","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"2023013108380203800_btz302-B30","year":"2018"},{"key":"2023013108380203800_btz302-B31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"2023013108380203800_btz302-B32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"2023013108380203800_btz302-B33","doi-asserted-by":"crossref","first-page":"2189.","DOI":"10.1186\/s12967-017-1119-6","article-title":"Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?","volume":"15","author":"Palmieri","year":"2017","journal-title":"J. Transl. Med"},{"key":"2023013108380203800_btz302-B34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"2023013108380203800_btz302-B35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.celrep.2015.08.066","article-title":"APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer","volume":"13","author":"Periyasamy","year":"2015","journal-title":"Cell Rep"},{"key":"2023013108380203800_btz302-B36","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2174\/092986706777585059","article-title":"Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic","volume":"13","author":"Ranieri","year":"2006","journal-title":"Curr. Med. Chem"},{"key":"2023013108380203800_btz302-B37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-017-0852-3","article-title":"An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation","volume":"19","author":"dos Reis","year":"2017","journal-title":"Breast Cancer Res"},{"key":"2023013108380203800_btz302-B38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1677\/erc.1.00776","article-title":"Mechanisms of tamoxifen resistance","volume":"11","author":"Ring","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"2023013108380203800_btz302-B39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"2023013108380203800_btz302-B40","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/ijc.29897","article-title":"DrugTargetInspector: an assistance tool for patient treatment stratification","volume":"138","author":"Schneider","year":"2016","journal-title":"Int. J. Cancer"},{"key":"2023013108380203800_btz302-B41","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.2007.12.2705","article-title":"Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP3C19 genotypes","volume":"25","author":"Schroth","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol"},{"key":"2023013108380203800_btz302-B42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12859-017-1667-z","article-title":"ImmunoNodes \u2013 graphical development of complex immunoinformatics workflows","volume":"18","author":"Schubert","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2023013108380203800_btz302-B43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin"},{"key":"2023013108380203800_btz302-B44","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1039\/C5MB00655D","article-title":"Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach","volume":"12","author":"Srihari","year":"2016","journal-title":"Mol. BioSyst"},{"key":"2023013108380203800_btz302-B45","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/bioinformatics\/btv770","article-title":"Multi-omics enrichment analysis using the GeneTrail2 web service","volume":"32","author":"St\u00f6ckel","year":"2016","journal-title":"Bioinformatics (Oxford, England)"},{"key":"2023013108380203800_btz302-B46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume":"10","author":"Tamborero","year":"2018","journal-title":"Genome Med"},{"key":"2023013108380203800_btz302-B47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"2023013108380203800_btz302-B48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41467-018-02938-1","article-title":"Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase","volume":"9","author":"Thiagarajan","year":"2018","journal-title":"Nat. Commun"},{"key":"2023013108380203800_btz302-B49","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.2147\/OTT.S142154","article-title":"The crossroads of breast cancer progression: insights into the modulation of major signaling pathways","volume":"10","author":"Velloso","year":"2017","journal-title":"OncoTargets Ther"},{"key":"2023013108380203800_btz302-B50","first-page":"1.","article-title":"Checkpoint blockade in the treatment of breast cancer: current status and future directions","volume":"500","author":"Wein","year":"2018","journal-title":"Br. J. Cancer"},{"key":"2023013108380203800_btz302-B51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrg3352","article-title":"Cancer pharmacogenomics: strategies and challenges","volume":"14","author":"Wheeler","year":"2013","journal-title":"Nat. Rev. Genet"},{"key":"2023013108380203800_btz302-B52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","article-title":"Principal component analysis","volume":"2","author":"Wold","year":"1987","journal-title":"Chemometr. Intell. Lab. Syst"},{"key":"2023013108380203800_btz302-B53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther"},{"key":"2023013108380203800_btz302-B54","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bar026","article-title":"International Cancer Genome Consortium Data Portal\u2014a one-stop shop for cancer genomics data","volume":"2011","author":"Zhang","year":"2011","journal-title":"Database (Oxford)"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btz302\/28545313\/btz302.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/35\/24\/5171\/48977944\/bioinformatics_35_24_5171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/35\/24\/5171\/48977944\/bioinformatics_35_24_5171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T03:13:47Z","timestamp":1721186027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/35\/24\/5171\/5481954"}},"subtitle":[],"editor":[{"given":"Russell","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":53,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btz302","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,15]]},"published":{"date-parts":[[2019,4,30]]}}}